Abstract
Topical corticosteroids are standard therapy in chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma, administered as nasal corticosteroids (NCS) and inhaled corticosteroid (ICS). Suboptimal adherence is associated with impaired health-related quality of life (1).
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Rhinology |
| ISSN | 0300-0729 |
| DOI | |
| Status | E-pub ahead of print - 5 jan. 2026 |